Welcome : Guest

Abbott India Ltd. (India) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Abbott India Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 193 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-12164
Price: $3500
Company Type: Public
Pages: 198
Date: January 2017
Market Data Tables: 193

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Abbott India Ltd.'s Revenues by Category (2015-2016) in Percentage for Sale of Products (Tablets, Injectables, Liquids, Capsules, and Others), and Other Operating Revenues......6
Table 2: Abbott Laboratories Ltd.’s (Operations) Revenues by Category (2015) in Percentage for Tablets, Injectables, Liquids, Capsules and Other Operating Revenues......7
Allergy Drugs......8
Table 3: Allergy and Rhinitis Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Avamys and Veramyst, Claritin and Clarinex, Zyrtec and Xyzal, and Others......8
Table 4: Allergy Care Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......9
Table 5: US Market (Private Label and Others) by Product (2015) - Percentage Share Breakdown by Values Sales for Allergy Care, Baby Food, Bakery, Bleach, Dairy, Deodorants, Hair Care, Ice Cream, Laundry Care, Oral Care, OTC, Pet Food, Pet Products, Retail Tissue, Sauces/Dressing, Skin Care, Sun Care, Toilet Care and VDS......10
Cardiology Therapeutics......11
Table 6: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......11
Table 7: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......12
Table 8: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......13
Pain Drugs......14
Table 9: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Others......14
Diabetes......15
Table 10: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......15
Table 11: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......16
Table 12: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......17
Table 13: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......18
Table 14: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......19
Table 15: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......20
Table 16: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......21
Table 17: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......22
Table 18: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......23
Table 19: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......24
Diabetes Drugs......25
Table 20: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......25
Table 21: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......26
Table 22: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......27
Table 23: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......28
Table 24: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......29
Table 25: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......30
Table 26: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......31
Table 27: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......32
Table 28: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......33
Table 29: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......34
Table 30: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......35
Non-Insulin Anti-Diabetic Drugs......36
Table 31: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......36
Diabetic Macular Edema (DME)......37
Table 32: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......37
Table 33: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......38
Insulin......39
Table 34: Insulin Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......39
Table 35: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......40
Table 36: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......41
Table 37: Insulin Market by Generation in China (2015) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......42
Table 38: Insulin Market by Product Type in the US (2015) - Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......43
DPP-4 Inhibitors......44
Table 39: DPP-4 Inhibitors Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Galvus & Galvumet (Novartis), Januvia & Janumet (MRK), Nesina & Kezano (Takeda), Onglyza & Kombiglyze (AZN/BMY) and Tradjenta & Jentadueto (BI/Lilly)......44
Table 40: DPP-4 Inhibitors Market in China (2015-2020) in RMB Million......45
Table 41: DPP-4 Inhibitors (Fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Galvusmet, Janumet, Janumet XR, Kombiglyze, Trajenta Duo and Zemimet......46
Table 42: DPP-4 Inhibitors (Non-fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Januvia, Nesina, Tradjenta, Zemiglo, and Others......47
Table 43: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......48
Table 44: DPP-4 Inhibitors Market in the US (2015) in No. of Prescriptions......49
DPP-4 type Diabetes Drugs......50
Table 45: DPP-4 type Diabetes Drugs Market in Japan (2015) in Yen Million......50
Urinary Incontinence Drugs......51
Table 46: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......51
Table 47: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......52
Vitamins and Dietary Supplements......53
Table 48: Vitamins and Supplements Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for China, European Union, Japan, USA and Others......53
Table 49: Vitamins and Supplements Retail Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Dietary Supplements, Paediatric Vitamins and Supplements, Tonics and Nutritive, and Vitamins......54
Table 50: Vitamins Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for A, B, C, E, and Others......55
Table 51: Vitamins Sales by Category Worldwide (2015) - Percentage Share Breakdown by Value for Animal, and Human......56
Table 52: Vitamins and Dietary Supplements (VDS) Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......57
Table 53: Vitamin and Supplements Market by Channel in the US (2015) - Percentage Breakdown by Value for Mass Marketers, Specialty Retailers, and Others......58
Table 54: Vitamins Sales by Category through Supermarkets, Drug Stores and Mass Merchandisers (including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) - Percentage Share Breakdown by Value for Adult Multivitamins, Calcium, Children's Multivitamins, Vitamin B, Vitamin C, Vitamins A&D, and Others......59
Table 55: Vitamins Sales through Supermarkets, Drug Stores, Mass Merchandisers (including Wal-Mart), Military Commissaries and Select Dollar and Club Chains by Sector in the US (2015) - Percentage Share Breakdown by Value for 1 & 2 Letter, Liquid Vitamins & Minerals, Mineral Supplements, and Multivitamins......60
Vaccines......61
Table 56: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......61
Women's Health Drugs......62
Table 57: Women's Health Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......62
Gastrointestinal Drugs......63
Table 58: Gastrointestinal Market Worldwide (2015) in US$ Million......63
Table 59: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......64
Central Nervous System (CNS) Drugs......65
Table 60: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......65
Table 61: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......66
Migraine Drugs......67
Table 62: Migraine Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Prescriptions for Amerge Generic (Naratriptan), Imitrex Generic (Sumatriptan), Maxalt Generic (Rizatriptan), Relpax (Pfizer), and Zomig Generic (Zolmitriptan)......67
Dermatological Drugs......68
Table 63: Dermatological Drug Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......68
Table 64: Dermatology Drugs Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......69
Table 65: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......70
Table 66: Dermal Substitutes Chronic Wound Market by Category in the US (2015) - Percentage Share Breakdown by Value for Diabetic Foot Ulcer, Pressure Ulcer and Venous Leg Ulcer......71
Table 67: Prevalence & Severity of Actinic Keratoses Market by Category in the US (2015) - Percentage Share Breakdown by Value for Minimal, Moderate, Severe, and Others......72
Drug-Eluting Stent (DES)......73
Table 68: Drug-Eluting Stent (DES) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for ABT Xience, MDT Endeavor and Resolute, and BSX......73
Table 69: Stent Market by Category in the US (2015) - Percentage Share Breakdown by Value for Bare Stents and Drug-Eluting Stents......74
Table 70: Stent Market by Category in Japan (2015) - Percentage Share Breakdown by Value for Bare Stents and Drug-Eluting Stents......75
Table 71: Stent Market by Category in China (2015) - Percentage Market Share Breakdown by Value for Bare Stents and Drug-Eluting Stents......76
Table 72: Stent Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Bare Stents and Drug-Eluting Stents......77
Respiratory Drugs......78
Table 73: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......78
Table 74: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......79
Hormone Therapy......80
Table 75: Hormone Therapy Treatment Market by Specialist Type Worldwide (2015) - Percentage Share Breakdown by Value for Oncologists, Urologists and Others......80
Table 76: Female Hormone Treatment Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Hormone Replacement Therapy and Others......81
Table 77: Female Hormone Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Estrogen, Hormone Replacement Therapy and Vegetable Female Hormone......82
Table 78: Female Hormone Treatment Market by Product in Korea (2015) - Percentage Share Breakdown by Value for Natural Estrogen Therapy and Others......83
Growth Hormones......84
Table 79: Growth Hormone Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......84
Table 80: Growth Hormone Market by Growth Disorder Indication in Europe (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Others......85
Table 81: Growth Hormone Market by Growth Disorder Indication in Japan (2015) - Percentage Share Breakdown by Value for Pediatric Growth Hormone Deficiency (GHD) and Turner Syndrome......86
Table 82: Growth Hormone Market by Growth Disorder Indication in the US (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Idiopathic Short Stature (ISS), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Others......87
Human Growth Hormones (hGH)......88
Table 83: Human Growth Hormone (hGH) Market by Growth Disorder Indication Worldwide (2015) - Percentage Share Breakdown by Value for Idiopathic Short Stature, Pediatric Growth Disorder Deficiency (GHD), Turner Syndrome and Others......88
Table 84: Human Growth Hormone Sales by Product in the US (2015) - Percentage Share Breakdown by Value for Genotropin (Pfizer), Humatrope (Eli Lilly), Norditropin (Novo Nordisk), Nutropin (Roche), Saizen, serostim (Merck KGaA) and Others......89
Pediatric Growth Hormone Deficiency (GHD)......90
Table 85: Pediatric Growth Hormone Deficiency (GHD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......90
Table 86: Pediatric Growth Hormone Deficiency (GHD) Market by Product in the US (2015) - Percentage Share Breakdown by Value Genotropin, Humatrope, Norditropin and FlexPro (NordiFlex), Nutropin AQ and Others......91
Adult Growth Hormone Deficiency (GHD)......92
Table 87: Adult Growth Hormone Deficiency (GHD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe and United States......92
Gastroenterology......93
Table 88: Immunology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dermatology, Gastroenterology, and Rheumatology......93
Allergy Care Products......94
Table 89: Market Shares of Leading Allergy Immunotherapy Treatment Providers Worldwide (2015) - Percentage Breakdown by Value for ALK-Abelló, Greer Laboratories, Inc., and Others......94
Table 90: Market Shares of Leading Allergy Immunotherapy Treatment Providers in the UK (2015) - Percentage Breakdown by Value for ALK, Allergopharma, Allergy Therapeutics, HAL Allergy, Leti/Novartis, Stallergenes, and Others......95
Table 91: Market Shares of Leading Allergy Care Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Sanofi S A, Private Label and Others......96
Table 92: Allergy Drug Market in the UK (2015) - Percentage Share Breakdown by Value for Allegra, Allelock, Clarinex, Claritin, Zyrtec, and Others......97
Cardiology Therapeutics......98
Table 93: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......98
Pain Management Drugs......99
Table 94: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......99
Table 95: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......100
Table 96: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......101
Table 97: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......102
Table 98: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Others......103
Table 99: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......104
Diabetes Drugs......105
Table 100: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......105
Table 101: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......106
Table 102: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......107
Insulin......108
Table 103: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......108
Table 104: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......109
Table 105: Market Shares of Leading Fast & Intermediate Type Insulin Producers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company, Novo Nordisk, Sanofi S.A. and Others......110
Table 106: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......111
Table 107: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......112
Table 108: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......113
Table 109: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......114
Table 110: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......115
Table 111: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......116
Table 112: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......117
Second-Generation Insulin......118
Table 113: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co., Ltd.......118
Third-Generation Insulin......119
Table 114: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......119
Human Insulin......120
Table 115: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......120
DPP-4 Inhibitors......121
Table 116: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......121
Table 117: Market Shares of Leading DPP-4 Inhibitors for Treatment of Diabetes in Japan (2015) - Percentage Share Breakdown by Value for Equa, Glactiv, Januvia, Nesina, and Others......122
Table 118: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......123
Sitagliptin/Metformin......124
Table 119: Market Shares of Leading Sitagliptin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Istavel and Januvia......124
Table 120: Market Shares of Leading Sitagliptin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc. and Sun Pharmaceutical Industries Ltd.......125
Table 121: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......126
Table 122: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......127
Metformin......128
Table 123: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......128
Urinary Incontinence Therapeutics......129
Table 124: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......129
Vitamins......130
Table 125: Market Shares of Leading Vitamins Producers Worldwide (2015) - Percentage Share Breakdown by Value for Adisseo, BASF, DSM and Others......130
Table 126: Market Shares of Leading Vitamins Suppliers Worldwide (2015) - Percentage Breakdown by Value for Adisseo, BASF SE, Koninklijke DSM N.V., and Others......131
Table 127: Market Shares of Leading Vitamin Manufacturers through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Bausch & Lomb, Inc., Bayer AG, Church & Dwight Co., Inc., Pfizer, Inc., Reckitt Benckiser Group plc, and Others......132
Table 128: Market Shares of Leading Vitamins Producers in the US (2015) - Percentage Share Breakdown by Value for Church & Dwight Co., Inc., and Others......133
Table 129: Market Shares of Leading Vitamin and Supplement Retailers in the US (2015) - Percentage Breakdown by Value for General Nutrition Centers, Inc., The Vitamin Shoppe, Whole Foods Market IP. L.P., and Others......134
Table 130: Market Shares of Leading Vitamins & Dietary Supplement Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Procter & Gamble Co., Private Label and Others......135
Vitamins (1 & 2 Letter)......136
Table 131: Market Shares of Leading Vitamin (1 & 2 Letter) Manufacturers through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Church & Dwight Co. Inc., NBTY, Inc., Pharmavite, LLC, Rexall Sundown, Inc., Private Label, and Others......136
Table 132: Market Shares of Leading Vitamin (1 & 2 Letter) Manufacturers through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for NBTY, Inc., Pharmative, LLC, Rexall Sundown, Inc., Private Label, and Others......137
Table 133: Market Shares of Leading Vitamin (1 & 2 Letter) Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Church & Dwight Co. Inc., NBTY, Inc., Pharmavite, LLC, Rexall Sundown, Inc., Private Label, and Others......138
Table 134: Market Shares of Leading Vitamin (1 & 2 Letter) Brands through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Nature Made, Nature’s Bounty, Sundown Naturals, Private Label, and Others......139
Adult Gummy Vitamins......140
Table 135: Market Shares of Leading Adult Gummy Vitamin Brands through Food Stores, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for One-A-Day(Bayer), Vitafusion, Private Label, and Others......140
Liquid Vitamins......141
Table 136: Market Shares of Leading Liquid Vitamin & Mineral Brands Through Drug Store in the US (2015) - Percentage Breakdown by Value for Alacer Emergen-C, Emergen-C, Joint Juice, Private Label, and Others......141
Table 137: Market Shares of Leading Liquid Vitamin & Mineral Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Alacer Corporation, Mead Johnson & Co., LLC, Neurobrands, LLC, Premier Nutrition Corporation, Private Label, and Others......142
Table 138: Market Shares of Leading Liquid Vitamin/Mineral Manufacturers through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Alacer Corporation, Mead Johnson & Co., LLC, Neurobrands, LLC, Private Label, and Others......143
Multivitamins......144
Table 139: Market Shares of Leading Multivitamin Brands through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Airborne, Centrum, Centrum Silver, Flintstones, Private Label, and Others......144
Table 140: Market Shares of Leading Multivitamin Brands through Supermarkets, Drug Stores, Mass Merchandisers (including Wal-Mart) Military Commissaries and Select Dollar and Club Chains in the US (2015) - Percentage Breakdown by Value for Airborne, Bausch and Lomb PreserVision, Centrum Silver, One A Day VitaCraves, Private Label, and Others......145
Table 141: Market Shares of Leading Multivitamin Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Share Breakdown for Bausch & Lomb, Inc., Bayer AG, Church & Dwight Co., Inc., Pfizer, Inc., Pharmative, LLC, Reckitt Benckiser Group plc, Private Label, and Others......146
Table 142: Market Shares of Leading Multivitamin Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Airborne (Reckitt Benckiser Group plc), Bausch & Lomb Inc., Bayer AG, Church & Dwight Co., Inc., Nature’s Way Products, LLC, Pfizer, Inc., Private Label, and Others......147
Vaccines......148
Table 143: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......148
Diphtheria and Tetanus Vaccines......149
Table 144: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......149
Hepatitis A Vaccines......150
Table 145: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......150
Hepatitis B (Recombinant) Vaccines......151
Table 146: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......151
Hepatitis A and Typhoid Polysaccharide Vaccines......152
Table 147: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......152
Human Papillomavirus Vaccines......153
Table 148: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......153
Human Rotavirus Vaccines......154
Table 149: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......154
Influenza Vaccines......155
Table 150: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......155
Measles, Mumps and Rubella Vaccines......156
Table 151: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......156
Tetanus Toxoid, reduced Diphthera Vaccines......157
Table 152: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......157
Typhoid Vaccines......158
Table 153: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......158
Varilrix Vaccines......159
Table 154: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......159
Women's Health Therapeutics......160
Table 155: Market Shares of Leading Women's Health Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Merck Ltd., Novo Nordisk A/S, Pfizer, Inc., and Others......160
Sleep Aid Drugs......161
Table 156: Market Shares of Leading Sleep Disorders Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Sanofi S.A., and Others......161
Table 157: Sleep Aid Drugs Market by Product Type in the US (2015) - Percentage Share Breakdown by Prescriptions for Lunesta Generic Ambien(Sanofi), and Lunesta Generic(Sunovion)......162
Gastrointestinal Drugs......163
Table 158: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......163
Table 159: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......164
Table 160: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private-Label and Others......165
Table 161: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......166
Table 162: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......167
Central Nervous System (CNS) Medicines......168
Table 163: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......168
Table 164: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......169
Dermatological Products......170
Table 165: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......170
Table 166: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......171
Table 167: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......172
Table 168: Market Shares of Leading Drugs for Treatment of Skin Infection in the US (2015) - Percentage Share Breakdown by Value for CUBICIN, VANCOMYCIN, ZYVOX IV and Others......173
Anti-Infectives......174
Table 169: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Others......174
Antacid Tablet......175
Table 170: Market Shares of Leading Antacid Manufacturers by Value Sales at Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown for Boehringer Ingelheim Pharmaceuticals, Inc., Glaxosmithkline plc, Novartis Consumer Health, Inc., Private label, Procter and Gamble Co., and Others......175
Table 171: Market Shares of Leading Antacid (Tablet) Manufacturers by Value Sales at Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline plc, Novartis Consumer Health, Inc., Private Label, Procter and Gamble Co., Procter and Gamble Co., and Others......176
Table 172: Market Shares of Leading Antacid Tablet Manufacturers by Value Sales at Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown for Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline plc, Novartis Consumer Health, Inc., Private Label, Procter and Gamble Co., and Others......177
Drug-Eluting Stent (DES)......178
Table 173: Market Shares of Leading Drug-Eluting Stent (DES) Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Boston Scientific Corporation, and Medtronic, Inc.......178
Retail Meal Replacement......179
Table 174: Market Shares of Leading Retail Meal Replacement Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Abt Foods Retailing India, Ltd., Atkins Nutritionals, Herbalife International, Kellogg Company, Otsuka Pharmaceutical Co., Ltd., Unilever, and Others......179
Respiratory Therapeutics......180
Table 175: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......180
Human Growth Hormones (HGH)......181
Table 176: Market Shares of Leading Human Growth Hormones (HGH) Producers Worldwide (2015) - Percentage Breakdown by Value for Eli Lilly and Company (Humatrope), Merck KGaA (Saizen,Serostim), Novo Nordisk A/S (Norditropin), Pfizer Inc. (Genotropin), Roche Holding AG (Nutropin), Teva Pharmaceutical Industries Ltd. (Tev-Tropin) and Others......181
Table 177: Market Shares of Leading Growth Hormone Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company (humatrope), Novo Nordisk (Norditropin), Pfizer, Inc. (Genotropin), Roche Holdings AG (Nutropin) and Others......182
Table 178: Market Shares of Leading Human Growth Hormones (HGH) Producers in the US (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Genentech, Inc. and Roche Holding AG, Merck KGaA, Novartis International AG, Novo Nordisk A/S, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......183
Biochemistry Analyzers......184
Table 179: Market Shares of Leading Biochemistry Analyzers Manufacturers in the US (2015) - Percentage Breakdown by Value for Abbott India Ltd., Beckman Coulter, Inc., Johnson & Johnson, Roche AG, Siemens AG, and Others......184
Table 180: Market Shares of Leading Biochemistry Analyzers Manufacturers by Value Sales in China (2014) - Percentage Breakdown for Mindray Medical International Limited, and Others......185
Immunology Testing......186
Table 181: Market Shares of Leading Immunology Testing Providers in the US (2015) - Percentage Breakdown by Value for Abbott India Ltd., Beckman Coulter Inc., Johnson & Johnson, Roche AG, Siemens AG, and Others......186
Generic Pharmaceutical......187
Table 182: Global IV Generics Drug Market by Value Sales (2015) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......187
Table 183: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Others......188
Table 184: Market Shares of Leading Generics Manufacturers in Australia (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Aspen Pharmaceutical Holdings Ltd., Mylan, Inc., Sandoz and Others......189
Table 185: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......190
Table 186: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......191
Table 187: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......192
Table 188: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......193
Table 189: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Volume for Actavis plc, Mylan N.V., Sandoz, Teva Pharmaceutical Industries Ltd. and Others......194
Table 190: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Dr. Reddy’s Laboratories Ltd. and GlaxoSmithKline......195
Table 191: Market Shares of Leading Derma Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis plc, Perrigo Company plc, Sandoz, Taro Pharmaceutical Industries Ltd. and Others......196
Table 192: Market Shares of Leading Non-Branded Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis, Mylan N.V., Teva Pharmaceutical Industries Ltd. and Others......197
Table 193: Market Shares of Leading Generic Injectable Drug Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., Fresenius, Hospira, Inc., Novartis (Sandoz), and Others......198